Sarepta Therapeutics, Inc.

Q2 2021 13F Holders

Symbol
SRPT
CUSIP
803607100
Type
Equity
Class
COM
Num filers
340
Total reported value, excl. options
$5.04B
Manager Report Date Value ($000) Shares